Rethinking regulatory tiers: Medicare real-world evidence shows CAMP outcomes are independent of FDA regulatory classification

Authors

William H. Tettelbach, MD, FACP, FIDSA, FUHM, MAPWCA, CHWS¹ ² ³ ⁴*
David G. Armstrong, DPM, MD, PhD⁵
Travis Tucker, MA, MBA⁶
Thomas A. Davenport, MD⁷
Lynnette A. Morrison, MD⁸
David B. Alper, DPM, FFPM RCPS⁹
Jonathan Johnson, MD, MBA, CWSP, FAPWCA¹⁰
Lee C. Rogers, DPM, FFPM RCPS¹¹
Jeffery A. Niezgoda, MD, FACHM, MAPWCA, CHWS¹² ¹³
Jennie Feight, MS, CPC, CPMA, CPC-I¹⁴
Kevin Nolan, MD, MPH, FACS⁸ ¹⁵
Daniel Kapp, MD¹⁶
Naz Wahab, MD, FAAFP, MAPWCA¹⁷ ¹⁸ ¹⁹
Martha R. Kelso, RN, CHWS, DAPWCA, HBOT²⁰ ²¹ ²² ²³

Corresponding Author: tarpon@xmission.com